Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?

  • Brian Hu, Amir Goldkorn
  • Expert Review of Anticancer Therapy, September 2014, Taylor & Francis
  • DOI: 10.1586/14737140.2014.957190

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1586/14737140.2014.957190